Panel discussions
The biotech manufacturing sector is facing challenges to scale efficiently and maintain consistency. Failure to address these issues can lead to inconsistent product quality, regulatory setbacks, and limited patient access to critical therapies. New technologies such as AI-driven automation and flexible manufacturing platforms offer opportunities to enhance efficiency and resilience. Our panel will explore the transformative solutions shaping biotech manufacturing over the next three years.
May 6, 15:00-15:45, room MCH Lounge
| Name | Position | Institution |
|---|---|---|
| Daniel Wilhelm | Managing Director Health Industry Switzerland | Zühlke |
Zühlke is a global transformation partner, with engineering and innovation in our DNA. We excel in complex, regulated spaces including health and finance, connecting strategy, tech implementation, and operational services to help clients become more effective, resilient businesses.
